Journal of Pediatric Health Care
Volume 24, Issue 1 , Pages 34-41 , January 2010

Microalbuminuria and Heart Rate Variability in Adolescents With Diabetes

References 

  1. American Diabetes Association. (2008a). Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31, 596-615.
  2. American Diabetes Association. (2008b). Standards of medical care in diabetes–2008. Diabetes Care, 31(Suppl 1) , S12-S54.
  3. Boysen A, Lewin MA, Hecker W, Leichter HE, Uhlemann F. Autonomic function testing in children and adolescents with diabetes mellitus. Pediatric Diabetes. 2007;8:261–264
  4. Cowan MJ. Measurement of heart rate variability. Western Journal of Nursing Research. 1995;17:32–48discussion 101-111
  5. Coyer SM, Gallo AM. Secondary analysis of data. Journal of Pediatric Health Care. 2005;19:60–63
  6. Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  7. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. ISPAD clinical practice consensus guidelines 2006-2007. Microvascular and macrovascular complications. Pediatric Diabetes. 2007;8:163–170
  8. Dost A, Klinkert C, Kapellen T, Lemmer A, Naeke A, Grabert M, et al. Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with T1DM. Diabetes Care. 2008;31:720–725
  9. Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Annals of Internal Medicine. 1980;92(2 Pt 2):308–311
  10. Ewing DJ, Neilson JM, Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. British Heart Journal. 1984;52:396–402
  11. Faulkner MS, Hathaway DK, Milstead EJ, Burghen GA. Heart rate variability in adolescents and adults with T1DM. Nursing Research. 2001;50:95–104
  12. Faulkner MS, Quinn L, Rimmer JH, Rich BH. Cardiovascular endurance and heart rate variability in adolescents with type 1 or type 2 diabetes. Biological Research for Nursing. 2005;7:16–29
  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18:499–502
  14. Garg JP, Bakris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vascular Medicine. 2002;7:35–43
  15. Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD, et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia. 2000;43:561–570
  16. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology. 1987;59:256–262
  17. Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de Zeeuw D. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Current Opinions in Nephrology & Hypertension. 2006;15:631–636
  18. Lane JT, Ford TC, Larson LR, Chambers WA, Lane PH. Acute effects of different intensities of exercise in normoalbuminuric/normotensive patients with T1DM. Diabetes Care. 2004;27:28–32
  19. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New England Journal of Medicine. 1993;329:1456–1462
  20. Liese AD, D'Agostino RB, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, et al. The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118:1510–1518
  21. Maahs DM, Snively BM, Bell RA, Dolan L, Hirsch I, Imperatore G, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than T1DM: The SEARCH for Diabetes in Youth study. Diabetes Care. 2007;30:2593–2598
  22. Mayer-Davis EJ. T2DM in youth: Epidemiology and current research toward prevention and treatment. Journal of the American Dietetic Association. 2008;108(4 Suppl 1):S45–S51
  23. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115:1948–1967
  24. McVean JJF, Eickhoff JC, McDonald MJ. Prevalence of early microalbuminuria in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism. 2008;21:469–471
  25. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–1890
  26. Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS. The effect of intensive diabetes treatment on resting heart rate in T1DM: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care. 2007;30:2107–2112
  27. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, et al. Microalbuminuria and the risk for early progressive renal function decline in T1DM. Journal of the American Society of Nephrology. 2007;18:1353–1361
  28. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with T1DM: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care. 2007;30:2523–2528
  29. Soltesz G, Patterson CC, Dahlquist G. Worldwide childhood T1DM incidence—what can we learn from epidemiology?. Pediatric Diabetes. 2007;8(Suppl 6):6–14
  30. Writing Group DE. Sustained effect of intensive treatment of T1DM mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003;290:2159–2167
  31. Zandbergen AA, Vogt L, de Zeeuw D, Lamberts SW, Ouwendijk RJ, Baggen MG, et al. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with T2DM and microalbuminuria. Diabetes Care. 2007;30:3119–3121

PII: S0891-5245(09)00026-1

doi: 10.1016/j.pedhc.2009.01.002

Journal of Pediatric Health Care
Volume 24, Issue 1 , Pages 34-41 , January 2010

Article Tools